Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4001032 | Urologic Oncology: Seminars and Original Investigations | 2008 | 8 Pages |
Abstract
TRAIL-R4 decoy receptor expression is strongly correlated with PSA recurrence, which is suggestive of poor prognosis. High levels of TRAIL-R4 expression but low levels of TRAIL death ligand expression are connected to decreased survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ismail T. M.D., Ahter D. Ph.D., Bahri Ph.D., Thomas S. Ph.D., Salih V.M.D., Ph.D.,